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S U M M A R Y
Background: Hand, foot, and mouth disease (HFMD) is an acute viral disease caused by human
enteroviruses, especially human enterovirus 71 (HEV71) and coxsackievirus A16 (CVA16), and mainly
affects infants and young children. After the outbreak in 2008 in Fuyang, China, HFMD was classiﬁed as a
category C notiﬁable infectious disease by the Ministry of Health of China.
Methods: In this study, we report the epidemiologic and clinical manifestations of HFMD in Guangdong
Province, China in 2010, and characterize HEV71 and CVA16 isolated from clinical specimens.
Results: Among the 542 HFMD patients, 495 (91.3%) were positive for enterovirus as detected by real-
time reverse transcriptase PCR; 243 were positive for HEV71 (49.1%, 243/495) and 114 were positive for
CVA16 (23.0%, 114/495). Most of the affected children were aged 5 years or under (93.7%, 508/542).
Phylogenetic analyses of VP1 gene sequences showed that the HEV71 isolates belonged to C4a
subgenotype, and CVA16 isolates belonged to B1 genotype.
Conclusions: Our results demonstrate that HEV71 and CVA16 are the primary causative agents
responsible for HFMD in Guangdong Province, and their co-circulation poses a potential risk to public
health.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hand, foot, and mouth disease (HFMD) is caused by enter-
oviruses, most commonly human enterovirus 71 (HEV71) and
coxsackievirus A16 (CVA16).1,2 This disease usually affects
children below the age of 10 years, mainly those in the range of
1–5 years.3 The clinical presentations are usually mild and include
fever and blister-like eruptions in the mouth and/or skin rashes on
the hands and feet.4 In some cases, HFMD can result in severe
complications like encephalitis, aseptic meningitis, pulmonary
edema, hemorrhage-related acute ﬂaccid paralysis, myocarditis,
and even death.5–8 In the spring of 2008, an HFMD outbreak caused
by HEV71 occurred in Fuyang and later spread to the South China
area. After that, HFMD was classiﬁed as a category C notiﬁable
infectious disease by the Ministry of Health of China in the same
year.3,4,9
A variety of neurological diseases, including encephalitis,
aseptic meningitis, and pulmonary edema, can sometimes develop
in HEV71-associated HFMD. In contrast, CVA16-associated HFMD
has a lower incidence of severe complications.10 Therefore it is* Corresponding author. Tel.: +86 10 66948604.
E-mail address: qincf@bmi.ac.cn (C.-F. Qin).
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http://dx.doi.org/10.1016/j.ijid.2013.04.003important to identify the causative virus to anticipate the
associated risk with infection. While HEV71 and CVA16 infections
are the most common causes of HFMD, other members of the
human Enterovirus genus, such as echovirus 9 (E9), coxsackievirus
A4 (CVA4), coxsackievirus A10 (CVA10), and coxsackievirus B5
(CVB5), can also cause HFMD.11–13 Therefore, in clinical therapeu-
tics, it is important to identify the causative virus.
HEV71 viruses are classiﬁed into three genotypes – A, B, and
C – and genotypes B and C are further divided into ﬁve
subgenotypes based on their VP1 gene sequences.14–17 In
previous studies conducted in Malaysia and Taiwan, where
HFMD epidemics are prevalent, genotype replacement has
been documented for these viruses. In Malaysia, the predomi-
nant genotypes were B in 1997, C in 1998, B in 2000, C in early
2003, and B in late 2003 and 2005–2006.18 In Taiwan, the
predominant HEV71 genotypes were C2 in 1998, B4 in 1999–
2003, C4 in 2004–2006, and B5 in 2008.19 In Europe, only the
C1, C2, and C4 genotypes were detected during 1988–2000, and
in 2000–2009, the only genotype detected was C.20 Genotype C
is the only HEV71 genotype found in Mainland China since
1998.4 During the 2008 HFMD outbreak, C4a was the only
HEV71 genotype detected. In Shenzhen, lineages B and C co-
circulated in 1999 and 2000, but only lineage C was detected
from 2001 to 2004.2ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Primers used for cDNA synthesis, PCR ampliﬁcation, and sequencing
Primer Sequence (50–30) Location
HEV71-F GGAGATAGGGTGGCAGAT 2443–2461
HEV71-R GGTTGGCTTTGAATAGGT 3271–3255
CVA16-F CTGGGTACTTTGACTATTACAC 2262–2283
CVA16-R GTTGTTATCTTGTCTCTACTAGTG 3327–3304
S.-J. He et al. / International Journal of Infectious Diseases 17 (2013) e1025–e1030e1026In this study, we investigated the etiology of HFMD in
Guangdong Province, China in 2010, and analyzed the HEV71
and CVA16 genotypes isolated from clinical specimens.
2. Subjects and methods
2.1. Clinical information and specimen collection
The clinical information and samples were collected from
children diagnosed with HFMD upon presentation either as
inpatients or outpatients at Zhujiang Hospital from March to
December 2010 in Guangzhou, Guangdong Province, China. The
clinical information collected included symptoms, age, and gender.
Rectal swabs were collected from the patients and kept at 80 8C
until examination for enterovirus by real-time reverse transcrip-
tase PCR (RT-PCR), or until the virus had been isolated after
infection of rhabdomyosarcoma (RD) cells. Serum samples from
the patients were collected and stored immediately at 80 8C.
2.2. Real-time RT-PCR detection
Viral RNA was extracted from the clinical specimens using the
QIAamp Viral RNA Mini Kit (Qiagen, Germany) in accordance with
the manufacturer’s instructions and was subjected to real-time RT-
PCR (Da An Gene Co., Ltd, China). This real-time RT-PCR kit can
speciﬁcally detect pan-enterovirus (members of the Enterovirus
genus, PE), HEV71, and CVA16. The ﬂuorescence data were
analyzed using LightCycle 1.2 (Roche, Germany). Analysis of the
real-time data was used for the classiﬁcation of the virus as PE,
HEV71, or CVA16.
2.3. Laboratory tests
2.3.1. Serotype assays
Serotype tests were used to detect enteroviruses other than
HEV71 and CVA16. We used the previously described serotype-
speciﬁc primers for semi-nested RT-PCR.21 Positive specimens
from the PE tests that tested negative for both HEV71 and CVA16
were used for this assay. After ampliﬁcation, the PCR products
were subjected to electrophoresis on a 2% agarose gel. Small
variations in the sizes of the PCR products (350 to 400 bp) were
observed due to differences in the VP1 gene length in different
serotypes. PCR products were sequenced by Sangon Biotech Co.,
Ltd (Shanghai, China). The data were analyzed for homology using
a BLAST search program (http://blast.ncbi.nlm.nih.gov/Blast.cgi?-
PROGRAM=blastn&BLAST_PROGRAMS=megaBlast&PAGE_TYPE=-
BlastSearch&SHOW_DEFAULTS=on&LINK_LOC=blasthome).
2.3.2. Genotype assays
Some of the HEV71- and CVA16-infected specimens were used
to isolate the virus after culturing in RD cells. Cultures that
exhibited a characteristic enterovirus-induced cytopathic effect
were evaluated by RT-PCR and immunoﬂuorescence using
monoclonal antibodies against HEV71 and CVA16. Viral RNA
was extracted as above. The VP1 gene from the viral isolate was
ampliﬁed by RT-PCR using the appropriate primers designed for
HEV71 and CVA16 (Table 1). Both the reverse transcription
reactions and ampliﬁcation reactions were performed using the
One-Step RT-PCR Kit (Invitrogen, USA) in accordance with the
manufacturer’s instructions. After electrophoresis on a 1% agarose
gel, the VP1 gene sequences were determined by Sangon Biotech
Co., Ltd (Shanghai, China). The VP1 gene sequences from various
HEV71 and CVA16 isolates were aligned using ClustalW software.
Phylogenetic trees were constructed using the neighbor-joining
method of the MEGA 4.1 program, and stability of the nodes was
tested using the maximum composite likelihood method with abootstrap value of 1000 replications.22 All HEV71 and CVA16
strains identiﬁed in this study were compared with reference
strains. We also analyzed the amino acid sequences of these VP1
genes. The sequences were aligned using ClustalX biosoftware.
Homology and identity analysis were performed using DNAStar
software package.
2.4. Statistical analysis
The data were analyzed using SPSS 13.0 software. The
percentage of clinical complications was analyzed using the Chi-
square test. MEGA 4.1 was used to analyze the phylogeny of HEV71
and CVA16.
2.5. Ethical approval
Ethical approval was given by the Ethics Committee of the
Zhujiang Hospital of Southern Medical University with the
following reference number: ZJYY-2010-YXJYZX-003. The parents
of each subject gave informed written consent before the collection
of rectal swabs and serum samples.
3. Results
From March to December 2010, there were 542 inpatients and
outpatients with symptoms consistent with the clinical deﬁnition
of HFMD according to the diagnosis guidelines for HFMD of the
Ministry of Health of China.
3.1. Etiology
We selected real-time RT-PCR as the prescreening procedure for
etiology. From the 495 enterovirus infection cases reported, 243
were HEV71-positive (49.1%, 243/495), 114 were CVA16-positive
(23.0%, 114/495), and the rest were deﬁned as PE infections (28.5%,
141/495, HEV71- and CVA16-negative). Interestingly, three cases
were identiﬁed to be positive for both HEV71 and CVA16.
The 141 PE-infected cases were further analyzed by semi-
nested RT-PCR. Only 20 cases could be ampliﬁed and sequenced
successfully due to low virus loading and non-speciﬁc ampliﬁca-
tion. The data were analyzed for homology using a BLAST search
program. Among these 20 cases, 11 were deﬁned as CVA6, two
were CVA2, two were CVA10, and there was one case each of
CVA21, CVB2, CVB5, E16 (echovirus 16), and E25.
The HEV71- and CVA16-positive specimens (86/242 and 39/
107, respectively) were subjected to virus isolation after
infection of RD cells. Viruses were isolated from 47 of the
HEV71-positive specimens (54.7%) and 19 of the CVA16-positive
specimens (48.7%). The results of RT-PCR and immunoﬂuores-
cence using monoclonal antibodies against HEV71 and CVA16,
conﬁrmed the results of the real-time RT-PCR. We also
attempted to isolate virus from the 141 PE-positive specimens
using RD cells, but there was no characteristic enterovirus-
induced cytopathic effect observed in the RD cells. Real-time RT-
PCR, RT-PCR, and the immunoﬂuorescence assay were also
negative for these samples.
Figure 1. Gender and age distribution of 542 patients in 2010.
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Of the 542 patients, 349 were males and 193 were females. The
male-to-female ratio was 1.81:1, which is very close to the
surveillance results observed in Guangdong in 2008.4 The patients
ranged in age from 2 months to 14 years, with most being aged 5
years or below (93.7%, 508/542). Fifty-four patients from this age
group were aged under 1 year and comprised 9.96% of the total
patient population (Figure 1). The HFMD epidemic in Guangdong
lasted throughout the year, with two prevalence periods: the
signiﬁcant period from April to July (410/542) and a slight peak in
October (42/542) (Table 2).
3.3. Clinical manifestations
The majority of the HFMD patients exhibited mild clinical
presentations with fever (below 38.5 8C) and blister-like eruptions
on the hands, feet, and mouth mucosa. However, 47 patients
suffered from complications (Table 3) and two of the patients died
of the infection. Of these 47 severe cases, 35 tested positive for
HEV71, one tested positive for CVA16, seven tested positive for PE,
and four showed no positive result by real-time RT-PCR. Sera from
the seven PE-positive patients were tested by ELISA, and four of
these samples were HEV71-positive and three were negative for
both HEV71 and CVA16.
The male-to-female ratio was 2.62:1 (34:13) and more than half
of the patients were under 2 years of age (average 2.5 years), with
two patients under 6 months of age. The two patients (a boy and a
girl, both younger than 2 years) who died of the infection had
symptoms affecting the nervous system and were HEV71-positive.
Encephalitis was the most common complication in the analyzed
cases; 43 patients developed convulsions, vomiting, hypermyoto-
nia, and hypersomnia, and one patient suffered from aseptic
meningitis. Pneumonia was a cardinal symptom in four patients
and pulmonary edema was observed in one.
3.4. Phylogenetic analysis
In order to analyze the HEV71 and CVA16 genotypes from the
specimens, we ampliﬁed the VP1 gene of the isolated viruses. The
VP1 gene of 32 HEV71 isolated strains (68.1%, 32/47) and 13 CVA16
isolated strains (68.4%, 13/19) were successfully ampliﬁed and
sequenced. The failure of the ampliﬁcation in the other isolated
strains could be attributed to a mismatch between the primers and
the actual nucleotide sequence of the individual virus strains.
These EV71 isolates from the years 2009 and 2010 from
Guangdong Province were highly homologous, and the nucleotide
identity of VP1 proteins among different HEV71 strains wasTable 2
The distribution of etiology and complications of HFMD by month, 2010
Number of patients HEV71-pos
CAV16-neg
CVA16-pos
HEV71-neg
HEV71-neg
CVA16-neg
PE-pos
Mar 9 3 4 0 
Apr 63 29 16 11 
May 160 68 52 30 
Jun 136 69 29 31 
Jul 51 23 4 20 
Aug 30 15 0 10 
Sep 29 9 2 12 
Oct 42 14 4 20 
Nov 11 4 0 3 
Dec 11 6 0 4 
Total 542 240a 111a 141 
HFMD, hand, foot, and mouth disease; HEV17, human enterovirus 17; CVA16, coxsack
a Not including the three co-infection cases.calculated to be between 93.7% and 100%. The amino acids
sequence match was between 97.0% and 100%.
The neighbor-joining tree revealed that these isolates from
Guangdong Province were grouped as C4 genotype, most closely
related to the strains isolated from the same region in 2008–2009.
There were no apparent differences between these newly isolated
HEV71 strains and the typical strains isolated from the HFMD
outbreak in 2008 in Fuyang, Anhui. As these isolates had different
genotypes from those isolated from Taiwan, this demonstrates that
the HEV71 strains have distinct origin and transmission patterns in
Mainland China and Taiwan (Figure 2A).
Mutations in certain amino acids in the VP1 protein could alter
virulence and/or tropism of enteroviruses. For example, Huang and
colleagues reported that a glutamine to glutamic acid substitution
at VP1145 (VP1145E) showed greater viral titers and apoptosis,
which was responsible for an increased infectivity and lethality of
enterovirus 71 in mouse models.23 By alignment of these isolates
with typical strains from the 1998 outbreak in Taiwan and the
Chinese epidemic in 2008, as well as the prototype strain BrCr, we
found some meaningful sites located in the VP1 gene sequence that
probably affected the virulence or other biological characteristics
(Figure 3). Because of the lack of clinical samples and information
on integration of the VP1 gene, the virulence determinants need to
be investigated using directed mutagenesis.
CVA16 isolates from Guangdong Province from the years 2009–
2010 were found to be highly homologous, with nucleotide
identity of 90.2–100% and amino acid identity of 96.9–100%.
Generally, all CVA16 strains could be grouped into genotypes A and
B, as reported in a previous study.2 The prototype G10 and FY18
strain clustered separately from other CVA16 strains and wereRT-PCR-neg HEV71-pos
CVA16-pos
Clinical complications Deaths
2 0 2 0
7 0 0 0
10 0 11 1
6 1 12 0
4 0 3 0
4 1 4 0
6 0 4 0
3 1 7 0
4 0 2 0
1 0 2 1
47 3 47 2
ievirus A16; PE, pan-enterovirus; RT-PCR, real-time reverse transcriptase PCR.
Table 3
The main clinical complications and laboratory characteristics of HFMD in
Guangdong
Main complications Gender Pathogen
Male Female EV71 CVA16 PE RT-PCR-neg
Encephalitis 25 10 28 1 4 2
Aseptic meningitis 1 1 0 0 1 1
Pulmonary edema 1 1 2 0 0 0
Encephalitis and
pulmonary edema
7 0 4 0 2 1
Apositia 0 1 1 0 0 0
HFMD, hand, foot, and mouth disease; HEV17, human enterovirus 17; CVA16,
coxsackievirus A16; PE, pan-enterovirus; RT-PCR, real-time reverse transcriptase
PCR.
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other CVA16 strains and could be further divided into different
lineages. All 13 CVA16 strains in Guangdong were divided into two
different lineages on the basis of phylogenetic analysis (Figure 2B).
Four isolates belonged to subgenotype B1b and the other nine
strains grouped to B1a, suggesting that these isolates could have
originated from a different ancestral source, although they were
isolated from the same region. Additionally, these isolates wereFigure 2. Phylogenetic analysis of human enterovirus 71 (HEV71) and coxsackievirus A16
VP1 fragments (1600 bp). The isolated HEV71 strains of 2010 and 2009 are labeled with
sequence of the prototype of HEV71 strain BrCr (U22521). (B) The phylogenetic tree was
and 2009 are labeled with solid circles and solid squares. Other strains are taken from Ge
phylogenetic trees were constructed with MEGA 4.1 using the neighbor-joining methohighly homologous to the isolates from Shenzhen in 2009, but
exhibited a lower homology with strains isolated before 2005. This
phenomenon suggests that the newly isolated strains after 2009
from Guangdong may have the same origin, which was probably
different from the strains isolated from Shenzhen before 2005. In
view of frequent recombinations occurring in enteroviruses, the
entire genome information should be determined and recombi-
nant analysis should be performed in the future.
4. Discussion
The characterization of HFMD epidemics has been well
described, especially in the Asia-Paciﬁc region, including Taiwan,
Malaysia, Singapore, and Mainland China. HFMD was ﬁrst reported
in 1981 in Shanghai.9 The severe HFMD outbreak in Fuyang in 2008
resulted in the Ministry of Health of China classifying it as a
category C notiﬁable infectious disease. HFMD is an infectious
disease transmitted among children upon contact with the virus,
making it a societal as well as a medical issue. Generally, the
clinical symptoms of HFMD are mild and self-limiting, but the
complications that sometimes develop, especially from HEV71
infection, pose a health threat to children. Our study elaborates on
the epidemiology and etiology of HFMD and will help in the (CVA16) from Guangdong, 2010. (A) The phylogenetic tree was based on the HEV71
 solid circles and solid squares. Other strains are taken from GenBank, including the
 based on the CVA16 VP1 fragments (1777 bp). The isolated CVA16 strains of 2010
nBank, including the sequence of the prototype of CVA16 strain G10 (U05876). The
d and validated with 1000 bootstrap pseudo-replicates.
Figure 3. Amino acid sequence comparison of a part of the VP1 protein (amino acids 1–200) between isolated enterovirus 71 (EV71) strains from Guangdong and the reference
viruses EV71-BrCr (BrCr) and EV71-Fuyang strain (FYC4a).
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clinical therapies in the future.
Guangdong Province lies in the south of China, where summers
are longer than in most other provinces and the winters are not
severe. This speciﬁc geographic location and climate make HFMD
prevalent throughout the year in Guangdong, with a peak that is
longer than that in the other provinces. This increases the difﬁculty
of preventing and managing the disease.
In 2010 there were 542 inpatients and outpatients in our
hospital, mainly between April and July. The male-to-female ratio
was 1.81:1, and most were aged 5 years or under and were cared
for at home or in the kindergarten. The predominant causative
agent of HFMD was HEV71, which was primarily responsible for
the complications of the nervous system. In an earlier surveillance
of HFMD in Guangdong in 2008, 5.94% (11/185) of HFMD patients
developed complications. In our data, 8.67% (47/542) of infected
patients developed severe complications.4 This higher incidence of
complications reﬂects the fact that our hospital is one of the better
equipped hospitals in Guangdong, and patients with complications
are transferred from community hospitals to Zhujiang Hospital.
Our data are similar to those obtained from the 2008
surveillance of HFMD in Guangdong.4 The recurrence of a very
similar epidemic in 2010 suggests that public health authorities
need to work towards improving personal hygiene for children
aged less than 5 years, since the principle mode of infection for
HFMD is the fecal–oral route. Additionally, medical practitioners
need to pay particular attention to HEV71-associated HFMD
children, since it is known to cause severe complications in
approximately 15% of hospitalized cases.
Interestingly, our study revealed that although HEV71 was the
predominant virus in HFMD, the number of PE infections
(undetected by real-time PCR) was extremely high, even higher
than CVA16 infections. Using semi-nested RT-PCR to detect the
serotype of PE, we found CVA6 to be the predominant virus in the
PE-associated HFMD. In our opinion, the high number of PE in our
data is an artifact arising from recombination or mutation in the
region of the genome targeted by the real-time RT-PCR, whichreduced the sensitivity and speciﬁcity of detection. The other
explanation could be the development of neutralizing antibodies
in children who were exposed to the HEV71 and CVA16 viruses
during the 2008 outbreak of HFMD in Guangdong Province, China,5
resulting in a decreased rate of infection.
We also used ELISA to measure the IgM titer of serum from
HFMD patients. The sensitivity and speciﬁcity for HEV71 and
CVA16 detection using the ELISA were above 85% (data not
shown). From the 84 sera that were analyzed to detect the
antibody against HEV71, 26 tested positive for HEV71; also
another 29 sera tested positive for CVA16 from an analysis of 79
serum samples. Analysis of the data could not conclusively
establish the association of HEV71 or CVA16 with HFMD due to
the known cross-reactivity and false-positives. The data
however still indicated that some HEV71 and CVA16 infections
could not be deﬁned by the available test methods. In the cases
who developed complications, four of seven PE-associated
HFMD patients were determined to be HEV71-positive with
the ELISA. Therefore, the detection of PE should be taken more
seriously so that actual HEV71 infections are not overlooked.
Real-time RT-PCR combined with ELISA would enhance the
detection of HFMD and thereby have beneﬁts in clinical therapy.
Genotype C is the only HEV71 genotype found in China since
1998;3 the C4b strain mainly circulated in 1998–2004, whereas
C4a was predominant after 2004.4 The HEV71 genotype in the
HFMD outbreak in 2008 was exclusively classiﬁed as C4a.3 In our
study, the only HEV71 genotype in Guangdong in 2010 and 2009
was C4a. Although HEV71 is constantly evolving with an estimated
variation rate of 1.35  102 substitutions per nucleotide,14 the
sequence homology was conserved in cases involving mild
infection and cases involving complications. This result can be
attributed to a high degree of diversity and lack of potential for
recombination for HEV71.14 In Shenzhen, CVA16 lineages B and C
co-circulated in 1999 and 2000, but only lineage C was found from
2001 to 2004.2 In our data, CVA16 belonged to lineage B
(Guangdong in 2010), indicating that a genetic shift occurred
during these 6 years.
S.-J. He et al. / International Journal of Infectious Diseases 17 (2013) e1025–e1030e1030In China the C4 strain of HEV71 seems to have a stable antigenic
heredity with a shift in antigen speciﬁcity seldom reported.
Currently there is no effective vaccine or chemoprophylaxis for
HEV71, and therefore a stable antigen offers hope in our search for
a neutralizing epitope leading to an effective vaccine.
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